Selected research
Industry Growth & Trends
Global OTC Anti-Infective Drug Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global OTC Anti-Infective Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for OTC Anti-Infective Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for OTC Anti-Infective Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for OTC Anti-Infective Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the OTC Anti-Infective Drug market include Cipla, CR SANJIU, Lingrui, Sun Pharma, Bayer, GSK, MYLAN, NOVARTIS and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global OTC Anti-Infective Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The OTC Anti-Infective Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global OTC Anti-Infective Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to OTC Anti-Infective Drug.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global OTC Anti-Infective Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
OTC Anti-Infective Drug Market by Company
Cipla
CR SANJIU
Lingrui
Sun Pharma
Bayer
GSK
MYLAN
NOVARTIS
Johnson & Johnson
Teva
OTC Anti-Infective Drug Segment by Type
Antiviral
Antibacterial
Antifungal
Antiseptics
Other
OTC Anti-Infective Drug Segment by Application
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
OTC Anti-Infective Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Anti-Infective Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of OTC Anti-Infective Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Anti-Infective Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of OTC Anti-Infective Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Antiviral
- Antibacterial
- Antifungal
- Antiseptics
- Other
Applications
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
Companies covered
- Cipla
- CR SANJIU
- Lingrui
- Sun Pharma
- Bayer
- GSK
- MYLAN
- NOVARTIS
- Johnson & Johnson
- Teva
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global OTC Anti-Infective Drug Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global OTC Anti-Infective Drug Market Size by Region (2021-2032)
- 1.4.1 Global OTC Anti-Infective Drug Market Size by Region (2021-2026)
- 1.4.2 Global OTC Anti-Infective Drug Market Size by Region (2027-2032)
- 1.5 Key Regions OTC Anti-Infective Drug Market Size (2021-2032)
- 1.5.1 North America OTC Anti-Infective Drug Market Size Growth Rate (2021-2032)
- 1.5.2 Europe OTC Anti-Infective Drug Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific OTC Anti-Infective Drug Market Size Growth Rate (2021-2032)
- 1.5.4 South America OTC Anti-Infective Drug Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa OTC Anti-Infective Drug Market Size Growth Rate (2021-2032)
2 OTC Anti-Infective Drug Market by Type
- 2.1 Type Introduction
- 2.1.1 Antiviral
- 2.1.2 Antibacterial
- 2.1.3 Antifungal
- 2.1.4 Antiseptics
- 2.1.5 Other
- 2.2 Global OTC Anti-Infective Drug Market Size by Type
- 2.2.1 Global OTC Anti-Infective Drug Market Size Overview by Type (2021-2032)
- 2.2.2 Global OTC Anti-Infective Drug Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global OTC Anti-Infective Drug Market Size Forecasted by Type (2027-2032)
- 2.3 Global OTC Anti-Infective Drug Market Size by Regions
- 2.3.1 North America OTC Anti-Infective Drug Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe OTC Anti-Infective Drug Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific OTC Anti-Infective Drug Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America OTC Anti-Infective Drug Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa OTC Anti-Infective Drug Market Size Breakdown by Type (2021-2026)
3 OTC Anti-Infective Drug Market by Application
- 3.1 Type Introduction
- 3.1.1 Retail Pharmacies
- 3.1.2 Online Pharmacies
- 3.1.3 Hospital Pharmacies
- 3.2 Global OTC Anti-Infective Drug Market Size by Application
- 3.2.1 Global OTC Anti-Infective Drug Market Size Overview by Application (2021-2032)
- 3.2.2 Global OTC Anti-Infective Drug Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global OTC Anti-Infective Drug Market Size Forecasted by Application (2027-2032)
- 3.3 Global OTC Anti-Infective Drug Market Size by Regions
- 3.3.1 North America OTC Anti-Infective Drug Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe OTC Anti-Infective Drug Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific OTC Anti-Infective Drug Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America OTC Anti-Infective Drug Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa OTC Anti-Infective Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 OTC Anti-Infective Drug Industry Trends
- 4.2 OTC Anti-Infective Drug Industry Drivers
- 4.3 OTC Anti-Infective Drug Industry Opportunities and Challenges
- 4.4 OTC Anti-Infective Drug Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by OTC Anti-Infective Drug Revenue (2021-2026)
- 5.2 Global OTC Anti-Infective Drug Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global OTC Anti-Infective Drug Key Company Headquarters & Area Served
- 5.4 Global OTC Anti-Infective Drug Company, Product Type & Application
- 5.5 Global OTC Anti-Infective Drug Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global OTC Anti-Infective Drug Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 OTC Anti-Infective Drug Players Market Share by Revenue in 2025
- 5.6.3 2025 OTC Anti-Infective Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Cipla
- 6.1.1 Cipla Company Information
- 6.1.2 Cipla Business Overview
- 6.1.3 Cipla OTC Anti-Infective Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Cipla OTC Anti-Infective Drug Product Portfolio
- 6.1.5 Cipla Recent Developments
- 6.2 CR SANJIU
- 6.2.1 CR SANJIU Company Information
- 6.2.2 CR SANJIU Business Overview
- 6.2.3 CR SANJIU OTC Anti-Infective Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 CR SANJIU OTC Anti-Infective Drug Product Portfolio
- 6.2.5 CR SANJIU Recent Developments
- 6.3 Lingrui
- 6.3.1 Lingrui Company Information
- 6.3.2 Lingrui Business Overview
- 6.3.3 Lingrui OTC Anti-Infective Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Lingrui OTC Anti-Infective Drug Product Portfolio
- 6.3.5 Lingrui Recent Developments
- 6.4 Sun Pharma
- 6.4.1 Sun Pharma Company Information
- 6.4.2 Sun Pharma Business Overview
- 6.4.3 Sun Pharma OTC Anti-Infective Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Sun Pharma OTC Anti-Infective Drug Product Portfolio
- 6.4.5 Sun Pharma Recent Developments
- 6.5 Bayer
- 6.5.1 Bayer Company Information
- 6.5.2 Bayer Business Overview
- 6.5.3 Bayer OTC Anti-Infective Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Bayer OTC Anti-Infective Drug Product Portfolio
- 6.5.5 Bayer Recent Developments
- 6.6 GSK
- 6.6.1 GSK Company Information
- 6.6.2 GSK Business Overview
- 6.6.3 GSK OTC Anti-Infective Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 GSK OTC Anti-Infective Drug Product Portfolio
- 6.6.5 GSK Recent Developments
- 6.7 MYLAN
- 6.7.1 MYLAN Company Information
- 6.7.2 MYLAN Business Overview
- 6.7.3 MYLAN OTC Anti-Infective Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 MYLAN OTC Anti-Infective Drug Product Portfolio
- 6.7.5 MYLAN Recent Developments
- 6.8 NOVARTIS
- 6.8.1 NOVARTIS Company Information
- 6.8.2 NOVARTIS Business Overview
- 6.8.3 NOVARTIS OTC Anti-Infective Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 NOVARTIS OTC Anti-Infective Drug Product Portfolio
- 6.8.5 NOVARTIS Recent Developments
- 6.9 Johnson & Johnson
- 6.9.1 Johnson & Johnson Company Information
- 6.9.2 Johnson & Johnson Business Overview
- 6.9.3 Johnson & Johnson OTC Anti-Infective Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Johnson & Johnson OTC Anti-Infective Drug Product Portfolio
- 6.9.5 Johnson & Johnson Recent Developments
- 6.10 Teva
- 6.10.1 Teva Company Information
- 6.10.2 Teva Business Overview
- 6.10.3 Teva OTC Anti-Infective Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Teva OTC Anti-Infective Drug Product Portfolio
- 6.10.5 Teva Recent Developments
7 North America
- 7.1 North America OTC Anti-Infective Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America OTC Anti-Infective Drug Market Size by Country (2021-2026)
- 7.3 North America OTC Anti-Infective Drug Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe OTC Anti-Infective Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe OTC Anti-Infective Drug Market Size by Country (2021-2026)
- 8.3 Europe OTC Anti-Infective Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific OTC Anti-Infective Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific OTC Anti-Infective Drug Market Size by Country (2021-2026)
- 9.3 Asia-Pacific OTC Anti-Infective Drug Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America OTC Anti-Infective Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America OTC Anti-Infective Drug Market Size by Country (2021-2026)
- 10.3 South America OTC Anti-Infective Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa OTC Anti-Infective Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2021-2026)
- 11.3 Middle East & Africa OTC Anti-Infective Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst